Mabwell Biotech — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

An integrated biopharma company developing innovative antibody-based therapeutics for oncology and autoimmune diseases.

OncologyAutoimmune Diseases

Integrated antibody discovery and engineering platform for developing monoclonal antibodies, bispecifics, and ADCs with optimized properties.

Addressing significant unmet medical needs in China's large oncology market with novel antibody therapeutics.

Pipeline candidates may fail to demonstrate sufficient differentiation or efficacy in late-stage trials against established competitors.

Operates in the highly competitive Chinese antibody sector, vying for market share with numerous well-funded domestic and international biotechs.